Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients

Submitted: 18 March 2011
Accepted: 29 April 2011
Published: 1 August 2011
Abstract Views: 829
PDF: 454
HTML: 1011
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Multiple myeloma (MM) is a malignant plasma cell disease. Several proinflammatory cytokines produced by malignant plasma cells and bone marrow (BM) stromal cells are involved in the pathogenesis of the disease. We evaluated serum levels of the proinflammatory cytokines Interleukin-1β (IL-1β), Interleukin-6 (IL-6), Interleukin-8 (IL-8), macrophage inflammatory protein-1α (MIP-1α), in MM patients before treatment, and determined its significance in tumor progression. We also analyzed the correlation between measured parameters with proliferating cell nuclear antigen (PCNA). Forty-four MM patients and 20 healthy controls were studied. Serum levels of the proinflammatory cytokines were measured using enzyme-linked immunosorbent assay (ELISA), whereas PCNA value in the BM was determined by immunohistochemistry staining. The mean concentrations of the measured cytokines were significantly different among the three stages of disease, with higher values in advanced disease stage. Furthermore, patients with MM had significantly higher serum levels of the measured cytokines than in controls. A positive correlation was found between IL-6 with IL-1β, IL-8 and MIP-1α. Similarly, IL-8 and MIP-1α were positively correlated with markers of disease activity such as beta 2 microglobulin and LDH. The proliferation index, determined by PCNA immunostaining, was higher in advanced disease stage. Furthermore PCNA value correlated significantly with beta 2 microglobulin, LDH and the levels of the measured cytokines. Our results showed that the proliferative activity, as measured with PCNA, increases in parallel with disease stage. The positive correlation between PCNA and other measured mediators supports the involvement of these factors in the biology of myeloma cell growth and can be used as markers of disease activity and as possible therapeutic targets.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

G. Tsirakis, University Hospital of Heraklion
Department of Hematology
C. A. Pappa, Venizelion Hospital of Heraklion
Department of Hematology
M. Kaparou, University Hospital of Heraklion
Department of Hematology
V. Katsomitrou, University Hospital of Heraklion
Department of Hematology
A. Hatzivasili, Venizelion Hospital of Heraklion
Department of Hematology
T. Alegakis, University of Crete
Department of Social Medicine
A. Xekalou, University Hospital of Heraklion
Department of Pathology
E. N. Stathopoulos, University Hospital of Heraklion
Department of Pathology
M. Alexandrakis, University Hospital of Heraklion
Department of Hematology

How to Cite

Tsirakis, G., Pappa, C. A., Kaparou, M., Katsomitrou, V., Hatzivasili, A., Alegakis, T., … Alexandrakis, M. (2011). Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients. European Journal of Histochemistry, 55(3), e21. https://doi.org/10.4081/ejh.2011.e21

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Publication Facts

Metric
This article
Other articles
Peer reviewers 
2
2.4

Reviewer profiles  N/A

Author statements

Author statements
This article
Other articles
Data availability 
N/A
16%
External funding 
N/A
32%
Competing interests 
N/A
11%
Metric
This journal
Other journals
Articles accepted 
57%
33%
Days to publication 
135
145

Indexed in

Editor & editorial board
profiles
Academic society 
N/A